Medical Professionals:
Request a
Product Sample
 
Abstracts
 
HemCon is continually researching and advancing its knowledge on the efficacy with breakthrough studies and research.

Below are abstracts featuring HemCon dressings in new applications and studies around the world.
These abstracts are waiting to be peer reviewed and published in leading industry medical journals.

August 2007
Presented at Advanced Technology Applications for Combat Casualty Care (ATACCC 2007).
http://usaccc.org/ATACCC/index.htm
Chitosan-Based Dressing Decreases Bleeding Time From Hemodialysis Access Puncture Wound Bleeding.
Summary: 288 treatments (144 for each dressing) in 15 HD patients. Hemostasis achieved in 2 min 78.4%. 4 min 98.6%. no late out-of-hospital bleed. Avg. time to hemostasis improved to 2.9 vs. 18.6 minutes on arterial access site and 2.7 vs. 13.4 min for venous access site. The current study demonstrates the efficacy of the chitosan compared to a regular pad gauze with a significant decrease in time to hemostasis at dialysis puncture access sites. Read more

May 2007
Presented at 15th World Congress on Disaster and World Medicine.
http://www.wcdem2007.org/
Pre-hospital use of the HemCon® Bandage - Paramedics of Magen David Adom the Israeli national EMS system.
Summary: 8 cases – mostly skull, neck, groin and lower extremities bleeding during the second Lebanon war. All successful uses and stopped bleeding within 3-5 minutes. Read more

June 2006

Emergency Medicine and Critical Care Review
http://www.touchbriefings.com/.
From The Battlefield To The Street – Experience Of A Suburban Fire/EMS Agency With Chitosan Dressings.
Summary: The HemCon® Bandage can be successfully incorporated into the civilian EMS system. When properly applied, the HemCon® Bandage stops uncontrolled external hemorrhage when conventional methods fail. Read more
 Related Links:

Product Training is Available
Learn More

Breathing New Life into Resuscitation
Learn about the new SAVe ambient air ventilator from AutoMedx, offered exclusively through HemCon.
Learn More